Claficapavir (A1752) 是一种特异的核衣壳蛋白 (nucleocapsid protein) 抑制剂，IC50 约为1μM。Claficapavir 与 HIV-1 NC(Kd=20 nM) 强烈结合，从而抑制 NC 的伴侣特性，并导致对 HIV-1 具有良好的抗病毒活性。
| Cas No. | 2055732-24-4 |
| 别名 | A1752 |
| 分子式 | C17H12ClNO4S2 |
| 分子量 | 393.86 |
| 溶解度 | DMSO : 200 mg/mL (507.79 mM; ultrasonic and warming and heat to 40°C) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Claficapavir (A1752) is a specificnucleocapsid protein(NC) inhibitor with anIC50around 1 μM. Claficapavir strongly binds the HIV-1 NC (Kd=20 nM) thereby inhibiting the chaperone properties of NC and leading to good antiviral activity against the HIV-1[1]. Claficapavir binds directly to HIV-1 NC, thereby inhibiting specific chaperone functions of NC including Psi RNA dimerization and complementary trans-activation response element (cTAR) DNA destabilization, and it also disrupts the proper Gag processing[1]. |
